Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Inventory Average (2023 - 2026)

BioScience Health Innovations has reported Inventory Average over the past 4 years, most recently at $605344.0 for Q1 2026.

  • Quarterly Inventory Average rose 341.83% to $605344.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $605344.0 through Mar 2026, up 341.83% year-over-year, with the annual reading at $197333.5 for FY2025, 311.02% up from the prior year.
  • Inventory Average was $605344.0 for Q1 2026 at BioScience Health Innovations, up from $546924.0 in the prior quarter.
  • Over five years, Inventory Average peaked at $605344.0 in Q1 2026 and troughed at $14946.5 in Q2 2023.
  • The 4-year median for Inventory Average is $45843.0 (2024), against an average of $189306.0.
  • Year-over-year, Inventory Average surged 39.65% in 2024 and then surged 1114.59% in 2025.
  • A 4-year view of Inventory Average shows it stood at $35999.5 in 2023, then surged by 39.65% to $50272.0 in 2024, then surged by 987.93% to $546924.0 in 2025, then increased by 10.68% to $605344.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Inventory Average are $605344.0 (Q1 2026), $546924.0 (Q4 2025), and $503009.5 (Q3 2025).